To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

AAOS2018: Two-year results favour ECRB release versus PRP injection for lateral epicondylitis

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
March 2018

AAOS2018: Two-year results favour ECRB release versus PRP injection for lateral epicondylitis

Vol: 7| Issue: 3| Number:12| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Arthroscopic Debridement Versus Platelet-Rich Plasma Injection: A Prospective, Randomized, Comparative Study of Chronic Lateral Epicondylitis With a Nearly Two-Year Follow Up

Contributing Authors:
G Merolla P Paladini G Porcellini A Ricci G Zanoli

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

101 patients with lateral epicondylitis were randomized to either arthroscopic release of the extensor carpi radialis brevis or to platelet-rich plasma injections. Patients were assessed for pain, function, and grip strength over 104-week follow-up. While 8-week results for grip strength significantly favoured the PRP group compared to the arthroscopy group, 104-week results for pain, function, an...

Join the Conversation

Please Login or Join to leave comments.